5,524 filings
Page 3 of 100
6-K
qgf7lv3p8j8pkfq
6 Feb 24
Shingrix 18+ at Risk China Filing Review Accepted
7:44am
6-K
ppnu 0malk
6 Feb 24
GSK Presents Positive DREAMM-7 Phase III Data
6:51am
6-K
ij20d
1 Feb 24
Director/pdmr Shareholding
10:49am
6-K
a7d9k9y
1 Feb 24
Total Voting Rights
10:10am
6-K
nc9oizlnlnakeyafdwof
1 Feb 24
Statement: Zantac (Ranitidine) Litigation
6:51am
6-K
5n841
31 Jan 24
Final Results
1:00pm
6-K
30t05uye
29 Jan 24
Ema Accepts Arexvy Filing for Adults 50-59 at Risk
6:33am
6-K
rgyypyqt
29 Jan 24
European Commission Authorises Omjjara In the Eu
6:26am
6-K
01bh x2pg4d
19 Jan 24
Director/pdmr Shareholding
11:58am
6-K
04d51rplx8zpspelnj9k
17 Jan 24
Director/pdmr Shareholding
12:46pm
6-K
9dj9f0t648zz
17 Jan 24
Current Report
10:35am
6-K
xg60k
17 Jan 24
GSK Completes Sale of Shares In Haleon PLC
8:45am
6-K
am7keg7te794cnbbeunt
16 Jan 24
Director/pdmr Shareholding
1:10pm
6-K
e06co9o59bkv
10 Jan 24
Nucala Approved In China for Use In Severe Asthma
6:37am
6-K
ibnoilkhh9ey09xtda
9 Jan 24
GSK Enters Agreement to Acquire Aiolos Bio
6:16am
6-K
ekwwrysekqvm3
2 Jan 24
Total Voting Rights
10:35am
6-K
ywl7fvz8qwenre uwfb
21 Dec 23
Director/pdmr Shareholding
10:39am
6-K
euua7am5541vhc1z6zhi
18 Dec 23
Jemperli Plus Zejula Trial Meets Endpoint
6:34am
6-K
m245u
13 Dec 23
Director/pdmr Shareholding
11:02am
6-K
39fw8h6pwt90 uzn0r1
12 Dec 23
Japan Accepts Arexvy Filing for at Risk Adults
6:06am